By Dr. Mark Sircus
There should be no more confusion about whether or not marijuana is
effective for cancer patients. Medical marijuana is chemotherapy,
natural style, for all cancer patients. The two forms of hemp oil, one
with THC and CBD and the other CBD alone (which is pretty much legal
everywhere) provide the body with chemo therapeutics without the danger
and staggering side effects. There are many chapters in this book
about cancer patients using marijuana but in this one we present a
quick overview of the science that backs up the assertion that every
cancer patient and every oncologist should put medical marijuana on
their treatment maps.
What you will see in this chapter is
reference to many scientific studies that are all viewable on
governmental sites. The United States government is pathetic in its
dishonesty about medical marijuana both believing in it and holding patents for its medical use
and claiming at the same time that it has no medical use. The federal
government and still many states would rather throw innocent people in
jail for using medical marijuana than be honest about how much it can
help people recover from cancer and other diseases.
Below are
summaries to just some of the scientific research out there that
sustains the belief that medical marijuana will help people cure their
cancer.
One of the most exciting areas of current research in the
cannabinoid field is the study of the potential application of these
compounds as antitumor drugs.
CBD represents the first nontoxic exogenous agent that can
significantly decrease Id-1 expression in metastatic breast cancer
cells leading to the down-regulation of tumor aggressiveness.[1],[2]
The CBD concentrations effective at inhibiting Id-1 expression
correlated with those used to inhibit the proliferative and invasive
phenotype of breast cancer cells. Of the five cannabinoids tested:
cannabidiol, cannabigerol, cannnabichromene; cannabidiol-acid and
THC-acid, it was found that cannabidiol is the most potent inhibitor of cancer cell growth. Taken together, these data might set the bases for a cannabinoid therapy for the management of breast cancer.[3]
Results show that Δ9-tetrahydrocannabinol reduces tumor growth, tumor number, and the amount/severity of lung metastases in MMTV-neu mice.[4] Cannabinoids induce ICAM-1, thereby conferring TIMP-1 induction and subsequent decreased cancer cell invasiveness thus inhibits lung cancer invasion and metastasis.[5]
Non-small cell lung cancer (NSCLC) is the leading cause of cancer
deaths worldwide. Researchers have observed expression of CB1 (24%) and
CB2 (55%) in NSCLC patients. They have also shown that the treatment of
NSCLC cell lines (A549 and SW-1573) with CB1/CB2- and CB2-specific
agonists Win55,212-2 and JWH-015, respectively, significantly
attenuated random as well as growth factor-directed in vitro chemotaxis
and chemoinvasion in these cells.[6]
Researchers in lung cancers also reported that they observed significant reduction in focal adhesion complex,
which plays an important role in cancer migration. Medical marijuana
significantly inhibited in vivo tumor growth and lung metastasis (∼50%).[7]
In research on pancreatic cancer it was found that cannabinoids lead
to apoptosis of pancreatic tumor cells via a CB2 receptor and de novo synthesized ceramide-dependent up-regulation of p8 and the endoplasmic reticulum stress–related genes ATF-4 and TRB3. These findings may contribute to set the basis for a new therapeutic approach for the treatment of pancreatic cancer as reported by the National Cancer Institute. (snip) ...
NOTE: Read the complete article with all of the footnotes at this website:
http://drsircus.com/medicine/cannabis-cures-cancer
Dr Mark Sircus has authored an e-book titled: Medical Marijuana and it is listed at the end of the article:
Buy the new Medical Marijuana 2nd Edition eBook!
This blog is so nice to me. I will keep on coming here again and again. Visit my link as well..click link
ReplyDelete